This inventor holds 1 USPTO granted patent. Top assignee: Samsung Sdi Co., Inc.. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: Innovations of Kang-II Seo in Physiological Material Immobilization
Introduction
Kang-II Seo is a notable inventor based in Suwon, South Korea. He has made significant contributions to the field of biomedical engineering, particularly in the development of substrates for immobilizing physiological materials. His innovative work has led to the creation of a patented technology that enhances the stability and efficiency of physiological material applications.
Latest Patents
Kang-II Seo holds a patent for a "Substrate for immobilizing physiological material, and method of fabricating same." This invention provides a substrate that comprises a substrate material, a primer layer, and an immobilization layer. The primer layer is designed to enhance the attachment between the substrate and the immobilization layer. This technology allows for a stable, uniform, and high-density immobilization layer through a simple fabrication process.
Career Highlights
Kang-II Seo is currently employed at Samsung SDI Co., Inc., where he continues to innovate and develop new technologies. His work at Samsung SDI has positioned him as a key player in the advancement of materials used in biomedical applications. With a focus on practical solutions, he has contributed to the company's reputation for excellence in research and development.
Collaborations
Kang-II Seo has collaborated with notable colleagues, including Eun-Keu Oh and In-Ho Lee. These partnerships have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking technologies.
Conclusion
Kang-II Seo's contributions to the field of physiological material immobilization demonstrate his commitment to innovation and excellence. His patented technology not only enhances the efficiency of biomedical applications but also showcases the potential for future advancements in this critical area.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
